Analysis of dLGN reduction and <i>ephrin A5</i> expression in control and enucleated brains. by Olga O. Kozanian (811729)

“…(C) Area of <i>ephrin A5</i> expression in P1 dLGN. <i>Ephrin A5</i> expression within the dLGN of enucleated animals (78.98 ± 5.723%; <i>P</i> < 0.05) is significantly different than controls. …”

The <i>FZD5-GCM1</i> signaling axis is operative during human trophoblast syncytialization. by Jinhua Lu (267804)

“…(B) Expression of <i>GCM1</i> and <i>Syncytin1</i> detected by quantitative RT-PCR was down-regulated in BeWo cells upon <i>FZD5</i> knockdown. Values are normalized by GAPDH expression level and indicated as mean±SEM. …”

Basal medium with autologous plasma (AP) or autologous platelet lysate (APL) results in loss of cell surface marker phenotype and impaired growth respectively. by Ana Leda F. Longhini (226617)

Reduced capacity of TE and F<10 KDa to prime allogeneic responses <i>in vitro</i>. by Cristian R. Falcón (671586)

Fig 7 - by Maria Alice Miranda Bezerra Medeiros (11752002)

BCL11A expression was negatively regulated by hsa-miR-190b-5p. by Meihuan Chen (15456926)

“…(C) hsa-miR-190b-5p expression was decreased in 293T cells by hsa-miR-190b-5p inhibitors. …”

Figure 5 from Blocking Tryptophan Catabolism Reduces Triple-Negative Breast Cancer Invasive Capacity by Li-Wei Kuo (18175968)

Table_5_Bridging the Gap Between Morphometric Similarity Mapping and Gene Transcription in Alzheimer’s Disease.DOCX by Yang Zhang (30734)

L5 E-stimulation in S1 does not modulate sensory responses in S2 when POm is inactivated. by Carlos Castejon (2182382)

“…The experimental manipulation of the barrel cortex and POm is also shown. (B) Change (%) in mean S2 sensory response magnitude by stimulating L5 of S1 before (black) and after POm muscimol inactivation (gray). …”

Table_5_Bridging the Gap Between Morphometric Similarity Mapping and Gene Transcription in Alzheimer’s Disease.DOCX by Yang Zhang (30734)

Analysis of 5-HT release and signaling pathways in ADORA2B-deficient rat EC cells. by Rikard Damen (407681)

“…Antisense reduced hypoxic-mediated responses (compared to controls) and ameliorated cell responses to NECA and MRS1754. <b>5C)</b> Western blot identified decreased pMAPK (0.56±0.09), pCREB (0.75±0.11) and pTPH-1 (0.63±0.07) in antisense treated cells confirming down-regulation of these pathways with loss of ADORA2B expression under hypoxic conditions. …”

Effect of BCA treatment on aortic vasoreactivity. by Mohamed Siliman Misha (19232949)

Mean percentage of zone scores with standard error bars showing in which VMI-map zone each trial's track terminated at the end of 15 s sampling period. by Cordula V. Mora (456425)

Histogram showing the distribution of radio tracked Southern Black-throated Finch in the Desert Uplands region of Queensland, Australia. by John M. van Osta (16708866)

Reconstruction of the Evolutionary Dynamics of A(H3N2) Influenza Viruses Circulating in Italy from 2004 to 2012 by Erika Ebranati (120461)

“…<div><p>Background</p><p>Influenza A viruses are characterised by their rapid evolution, and the appearance of point mutations in the viral hemagglutinin (HA) domain causes seasonal epidemics. …”

Replacing i3 of Rs1 with that of 5-HT_1A results in a receptor, Rs1-i3-5-HT_1A, with weak G_isignaling. by Wei Chun Chang (43479)

“…<p>(A) Rs1-i3-5-HT_1A chimera decreased cAMP accumulation. …”

<i>In Situ</i> TEM Technique Revealing the Deactivation Mechanism of Bimetallic Pd–Ag Nanoparticles in Hydrogen Sensors by Xueqing Wang (210284)

Image_5_A Non-destructive Method to Quantify Leaf Starch Content in Red Clover.JPEG by Lea Antonia Frey (9521468)

AMPK activity and cell proliferation in HCC cell lines, PLC/PRF/5 and HepG2. by Jidong Cheng (548009)

“…Representative DNA histograms for PLC/PRF5 cells are shown. Data from three independent experiments are shown as mean ± SD. …”

DataSheet_2_The predictive value of free thyroxine combined with tubular atrophy/interstitial fibrosis for poor prognosis in patients with IgA nephropathy.csv by Bixia Yang (18550324)

“…The renal composite outcomes were defined as: (1) ESRD, defined as eGFR < 15 ml/(min·1.73 m²) or initiation of renal replacement therapy (hemodialysis, peritoneal dialysis, renal transplantation); (2) serum creatinine doubled from baseline; (3) eGFR decreased by more than 50% from baseline. The predictive value was determined by the area under the curve (AUC). …”